home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Ancient Diversity

  May, 2 2007 21:42
your information resource in human molecular genetics
An ancient enzyme drives diversification of immune receptors in lampreys, and resembles an enzyme with a similar function in mammals, according to a report published online in Nature Immunology.

Zeev Pancer and colleagues used computational analyses - 'genomic mining' - to look for molecular signatures in the lamprey genome. Clues to how lampreys diversify their antigen receptors, allowing them to combat any array of potential microbial threats, came from their identification of hundreds of short gene segments that encode bits of the antigen receptors. The authors also discovered evidence that these pieces can combine in almost an infinite array, thereby explaining how a diverse repertoire of receptors can be made.

The surprise the authors found in the lamprey genomic sequence was that these fish encode two enzymes similar to an enzyme called AID, which is essential for the production of different types of antibodies in mammals. In fact, further experiments performed in test tubes showed the lamprey enzymes can mutate target genes much like the mammalian AID enzyme. The new work suggests the ability to diversify antigen receptors occurred much earlier in evolution then previously thought and hence is an 'ancient adaptation'.

Author contact:

Zeev Pancer (University of Maryland Biotechnology Institute, Baltimore, MD, USA)
E-mail: pancer@comb.umbi.umd.edu

Additional contact for comment on paper:

David Schatz (Yale University School of Medicine, New Haven, CT, USA)
E-mail: david.schatz@yale.edu

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.